• Follow
  • Follow
  • Follow
  • Home
  • About
  • Scientific Foundation
  • Pipeline
    • 2AP01: AAVLP-HPV
    • 2AP07: AAVLP-EpCAM+
  • Investors
  • News
  • Contact
Press release: 2A Pharma AB raises SEK 27 million and signs exclusive worldwide license agreement

Press release: 2A Pharma AB raises SEK 27 million and signs exclusive worldwide license agreement

by admin | Jan 16, 2017 | 2017, Uncategorized

[pdf-embedder url=”https://2apharma.com/wp-content/uploads/2018/10/2A-Pharma-AB-Press-Release-2017-01-16.pdf” title=”2A Pharma AB Press Release 2017-01-16″]
Press release: 2A Pharma AB raises SEK 27 million and signs exclusive worldwide license agreement

Article about 2A Pharma in MedWatch

by admin | Jan 16, 2017 | 2017, Media

The following article was published in Danish pharma industry publication MedWatch on 16 January 2017. Click here to read the article (paywall).

Recent Posts

  • Poster preliminary proof-of-concept studies
  • 2A Pharma is attending the 23rd World Vaccine Congress Europe
  • 2A Pharma celebrates its 5th anniversary
  • Jeanette presents E-poster at IPVC 2021
  • Clinical trials explained

Recent Comments

    Denmark

    2A Pharma ApS
    Niels Jernes Vej 10
    9220 Aalborg Ost
    Denmark

    CVR No.: 3939 1597
    VAT No.: DK 3939 1597

    Sweden

    2A Pharma AB
    S:t Johannesgatan 2
    211 46 Malmö
    Sweden

    Registration No.:
    559090-2788
    VAT No.: SE55 9090 2788

    Pipeline

    2AP01: AAVLP-HPV
    2AP07: AAVLP-HNC

    Navigation

    About
    Scientific Foundation
    Pipeline
    Investors
    News
    Contact

    Contact

    +45 7214 6700
    info@2apharma.com

    • Follow
    • Follow
    • Follow

    Legal

    Terms & Conditions
    Privacy Policy